Standard Operating Procedure for Use of Certified Reference Standards in Analytical Method Development
| Department | Analytical Method Development |
|---|---|
| SOP No. | SOP/AMD/385/2025 |
| Supersedes | SOP/AMD/385/2022 |
| Page No. | Page 1 of 13 |
| Issue Date | 01/06/2025 |
| Effective Date | 04/06/2025 |
| Review Date | 01/06/2027 |
1. Purpose
To define a standardized procedure for the procurement, qualification, handling, storage, and use of Certified Reference Standards (CRS) in the Analytical Method Development department to ensure data accuracy, reliability, and regulatory compliance.
2. Scope
This SOP
applies to all certified reference standards used in the development, qualification, and validation of analytical methods for APIs and drug products. It includes reference materials procured from pharmacopoeias (e.g., USP, EP), commercial vendors, or in-house developed working standards.
3. Responsibilities
- Analytical Chemist: Responsible for receipt, verification, and proper handling of CRSs.
- Store Coordinator: Maintains inventory and storage records of CRSs.
- Quality Assurance: Reviews CRS qualification documents and approves in-house reference standards.
- AMD Manager: Ensures compliance with SOP and regulatory expectations.
4. Accountability
The Head of Analytical Method Development is accountable for ensuring the availability, qualification, traceability, and appropriate usage of CRSs in method development and validation.
5. Procedure
5.1 Procurement of Certified Reference Standards
- Procure CRS from official sources (e.g., USP, EP, BP) or qualified vendors with traceability documentation and CoA (Certificate of Analysis).
- Document vendor approval and purchase justification (Annexure-1).
5.2 Receipt and Verification
- Inspect CRS packaging upon receipt for integrity, labeling, and compliance with purchase order.
- Verify the following:
- Product name and catalog number
- Batch number and expiration date
- Storage conditions
- CoA traceability and lot-specific data
- Record the CRS in the inventory register (Annexure-2).
5.3 Storage Conditions
- Store CRSs as per manufacturer’s recommendations (e.g., 2–8°C for light-sensitive compounds).
- Use desiccators, refrigeration units, or light-protective containers as required.
- Ensure temperature and humidity monitoring logs are maintained daily.
5.4 Qualification of In-House Reference Standards
- When CRS is not available, prepare a primary working standard (PWS) using a validated lot of API.
- Compare analytical results of PWS with available pharmacopeial or certified standards.
- Evaluate purity by chromatographic methods, moisture by Karl Fischer, and calculate correction factors.
- Prepare a qualification report and submit to QA for approval (Annexure-3).
5.5 Usage and Documentation
- Label all standard containers with:
- Substance name and batch number
- Date of opening and expiry
- Storage condition and user initials
- Record usage in the CRS usage logbook (Annexure-4).
- Do not reuse containers once expired or contaminated.
5.6 Retesting and Re-qualification
- For CRSs without expiry date, perform retesting at defined intervals (e.g., annually) based on stability data.
- Document retest results and extend validity upon QA approval only.
5.7 Disposal
- Expired or rejected standards must be labeled ‘To Be Discarded’ and moved to the designated rejection area.
- Dispose of according to SOP on hazardous chemical disposal (refer to SOP/QA/054/2025).
6. Abbreviations
- CRS: Certified Reference Standard
- CoA: Certificate of Analysis
- PWS: Primary Working Standard
- QA: Quality Assurance
- SOP: Standard Operating Procedure
7. Documents
- Annexure-1: CRS Purchase and Verification Form
- Annexure-2: CRS Inventory Register
- Annexure-3: In-House Qualification Report Format
- Annexure-4: CRS Usage Logbook
8. References
- ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
- Pharmacopoeial standards (USP, EP, BP)
- 21 CFR Part 211.84 – Testing and Approval or Rejection of Components
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | Vaibhav Singh | Reema Pillai | Dr. Harshita Goyal |
| Designation | Analytical Chemist | QA Reviewer | Head – AMD |
| Department | Analytical Method Development | Quality Assurance | Analytical Method Development |
11. Annexures
Annexure-1: CRS Purchase and Verification Form
| Product Name | Catalog No. | Vendor | Batch No. | Expiry | Checked By |
|---|---|---|---|---|---|
| Caffeine CRS | USP-1101 | USP | CRS-1098 | 2026-09 | Reema Pillai |
Annexure-2: CRS Inventory Register
| Sr. No. | Name | Batch No. | Opened On | Expiry | Status |
|---|---|---|---|---|---|
| 1 | Paracetamol CRS | PCRS-1001 | 01/05/2025 | 31/05/2026 | Active |
Annexure-3: In-House Qualification Report Format
Report No.: AMD/IHQS/385/2025
Substance: Metformin Working Standard
Purity: 99.78% (by HPLC)
Moisture Content: 0.5%
Correction Factor: 0.994
Approved By: QA Manager
Annexure-4: CRS Usage Logbook
| Date | User | Standard | Batch No. | Purpose | Remarks |
|---|---|---|---|---|---|
| 01/06/2025 | V. Singh | Aspirin CRS | ASP-789 | Assay Calibration | Standard weighed and diluted |
Revision History
| Revision Date | Revision No. | Details | Reason | Approved By |
|---|---|---|---|---|
| 01/06/2025 | 2.0 | Expanded qualification and storage guidelines | Annual review | Dr. Harshita Goyal |
| 02/05/2022 | 1.0 | Initial version | New SOP | QA Head |